Nasus Pharma Ltd. (NSRX)
Market Closed
1 Sep, 20:00
AMEX AMEX Primary $
3. 83
-0.26
-6.3418%
$
35.31M Market Cap
- P/E Ratio
- Div Yield
15,674 Volume
- Eps
$ 4.08
Previous Close 
Want to track NSRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nasus Pharma Ltd. (NSRX) Statistics
Valuation metrics
Market Cap 35.31M
Enterprise value 27.6M
Trailing P/E (ttm) -3.94
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) -
Price/Book (mrq) 4.13
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.84
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 12.84K
Average volume (90 days) 20.84K
Price summary
52-Week low 1.98
52-Week high 9.5
Beta -
50-Day moving average 3.25
200-Day moving average 3.36
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.88%
Return on equity -1.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.07
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.77%
Book value per share (mrq) 0.99
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
